ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Elite Pharma (Surrey) Limited

Elite Pharma (Surrey) Limited is an active company incorporated on 1 February 2007 with the registered office located in West Molesey, Surrey. Elite Pharma (Surrey) Limited was registered 18 years ago.
Status
Active
Active since incorporation
Company No
06077954
Private limited company
Age
18 years
Incorporated 1 February 2007
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 21 January 2025 (9 months ago)
Next confirmation dated 21 January 2026
Due by 4 February 2026 (2 months remaining)
Last change occurred 6 years ago
Accounts
Submitted
For period 1 Dec31 Aug 2025 (9 months)
Accounts type is Micro Entity
Next accounts for period 31 August 2026
Due by 31 May 2027 (1 year 6 months remaining)
Address
Unit 2, Molesey Business Centre
Central Avenue
West Molesey
Surrey
KT8 2QZ
United Kingdom
Same address for the past 9 years
Telephone
02089393490
Email
Available in Endole App
People
Officers
4
Shareholders
3
Controllers (PSC)
1
Director • Secretary • British • Lives in UK • Born in Feb 1956 • Company Secretary
Director • British • Lives in UK • Born in Jun 1956
Director • British • Lives in UK • Born in Aug 1946
Mr Kiritkumar Meghji Shah
PSC • British • Lives in UK • Born in Jun 1956
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Herisse Limited
Ashokkumar Dahyabhai Patel and are mutual people.
Active
Vertical Pharma Resources Limited
Ashokkumar Dahyabhai Patel is a mutual person.
Active
Willows Investments Limited
Kiritkumar Meghji Shah is a mutual person.
Active
Integrated Pharmaceutical Services (Ips) Limited
Ashokkumar Dahyabhai Patel is a mutual person.
Active
Ipsco Limited
Ashokkumar Dahyabhai Patel is a mutual person.
Active
MSCG Ltd
Ashokkumar Dahyabhai Patel is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2025)
Period Ended
31 Aug 2025
For period 1 Dec31 Aug 2025
Traded for 9 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
3
Same as previous period
Total Assets
£23.22K
Decreased by £110 (-0%)
Total Liabilities
-£609
Increased by £609 (%)
Net Assets
£22.61K
Decreased by £719 (-3%)
Debt Ratio (%)
3%
Increased by 2.62% (%)
Latest Activity
Micro Accounts Submitted
11 Days Ago on 28 Oct 2025
Micro Accounts Submitted
2 Months Ago on 30 Aug 2025
Accounting Period Shortened
2 Months Ago on 18 Aug 2025
Confirmation Submitted
9 Months Ago on 6 Feb 2025
Amended Micro Accounts Submitted
1 Year 5 Months Ago on 11 Jun 2024
Amended Accounts Submitted
1 Year 6 Months Ago on 16 Apr 2024
Micro Accounts Submitted
1 Year 7 Months Ago on 3 Apr 2024
Confirmation Submitted
1 Year 9 Months Ago on 21 Jan 2024
Abridged Accounts Submitted
2 Years 5 Months Ago on 31 May 2023
Confirmation Submitted
2 Years 9 Months Ago on 12 Feb 2023
Get Credit Report
Discover Elite Pharma (Surrey) Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Micro company accounts made up to 31 August 2025
Submitted on 28 Oct 2025
Micro company accounts made up to 30 November 2024
Submitted on 30 Aug 2025
Current accounting period shortened from 30 November 2025 to 31 August 2025
Submitted on 18 Aug 2025
Confirmation statement made on 21 January 2025 with no updates
Submitted on 6 Feb 2025
Amended micro company accounts made up to 30 November 2023
Submitted on 11 Jun 2024
Amended accounts made up to 30 November 2022
Submitted on 16 Apr 2024
Micro company accounts made up to 30 November 2023
Submitted on 3 Apr 2024
Confirmation statement made on 21 January 2024 with no updates
Submitted on 21 Jan 2024
Unaudited abridged accounts made up to 30 November 2022
Submitted on 31 May 2023
Confirmation statement made on 1 February 2023 with no updates
Submitted on 12 Feb 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year